Jeremy Middleton

Jeremy Middleton is the current Chief Executive Officer of AJK Biopharmaceutical since October 2022. He also serves as the President of Elinic, LLC since May 2007. With a background in leading corporate development projects in the life sciences industry, he has extensive experience in strategic planning, M&A activities, and securing funding. Previous roles include VP Corporate Development at a biotech company focused on monoclonal antibody therapeutics and VP Business Development at Valera Pharmaceuticals. Prior to that, he held leadership positions at Neose Technologies, Inc. and Abbott Laboratories/BASF Pharma. Middleton's educational background includes a Bachelor of Science in Applied Chemistry from De Montfort University.